The Akt pathway contributes to prostate cancer development and progression through interacting with other cell signaling pathways important for cellular survival, proliferation, and differentiation, including the GSK-3β/β-catenin signaling pathway [10,11]. Here, GSK3B is linked to prostate carcinoma.